The 3 most recent market catalysts affecting $ASPN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $5
Barclays analyst David Anderson maintained an 'Underweight' rating on Aspen Aerogels (ASPN) but raised the price target from $4 to $5. This indicates that while the analyst sees so…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 85
Aspen Aerogels shares are trading higher after the company reported better-than-expected Q2 sales results and issued Q3 guidance above estimates.
This headline represents a significant positive corporate catalyst for Aspen Aerogels. Better-than-expected sales and strong forward guidance indicate robust operational performanc…
Aug 6, 2026
Corporate Catalyst
Neutral
Impact 85
Aspen Aerogels Sees Q3 GAAP EPS $(0.11)-$(0.07) vs $(0.14) Est; Sees Sales $65.000M-$80.000M vs $56.933M Est
Aspen Aerogels (ASPN) has released preliminary Q3 guidance indicating both earnings per share and revenue will surpass Wall Street's expectations. This is a significant positive de…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.